Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Chipping Away at the Quanta v. LG Electronics Patent Decision

Re: Chipping Away at the Quanta v. LG Electronics Patent Decision - Paul

posted on Jun 12, 2008 06:49AM

Agreed, it appears that the contract language (that I'm sure we're using as evidenced by the warnings by licensees to their subs) may protect our rights to go after subs of past licensees - and into the future.

The alternative approaches I suggest (focusing on 2nd tier only, or declaring past licenses with chip manufacturers void as the understood intent of the contracts cannot now be met) can be considered fall-back approaches should the desired approach not be successful.

IMO, this means that either our situation is unchanged, or that our approach must be altered to some degree but with very little (IMO) detrimental impact over the long haul. Not a bad position to be in, at all. We're good to go, or we're good to go!

JMHOs,

SGE

Share
New Message
Please login to post a reply